Anna Louise French

Insider Reports History

Entity
Individual
Location
C/O Qiming U.S. Healthcare, 11100 Ne 8 Th St, Suite 200, Bellevue, WA
Signature
/s/ Herb Cross, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anna Louise French:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 7.5K Jun 6, 2024 Direct

Insider Reports Filed by Anna Louise French

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JSPR Jasper Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
JSPR Jasper Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
JSPR Jasper Therapeutics, Inc. Apr 14, 2023 1 -$10.4K 4 Apr 14, 2023 Director
JSPR Jasper Therapeutics, Inc. Oct 12, 2022 1 $0 4 Oct 13, 2022 Director
JSPR Jasper Therapeutics, Inc. Mar 21, 2022 1 $0 4 Mar 23, 2022 Director
JSPR Jasper Therapeutics, Inc. Sep 24, 2021 0 $0 3 Oct 1, 2021 Director